Related Experiment Video
Updated: Feb 22, 2026
07:30
HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice
Published on: July 9, 2016
7.7K
Psychedelic Drugs in Biomedicine
Evan J Kyzar1, Charles D Nichols2, Raul R Gainetdinov3
1College of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA.
Trends in Pharmacological Sciences
|September 27, 2017
Summary
Psychedelic drugs like psilocybin show promise for treating conditions such as depression and anxiety. Further research is needed to understand their mechanisms, safety, and efficacy for patients.
Area of Science:
- Neuroscience
- Psychopharmacology
- Translational Medicine
Background:
- Psychedelic compounds, including lysergic acid diethylamide (LSD), mescaline, and psilocybin, significantly impact brain function and behavior.
- Following a period of limited research, psychedelics are re-emerging as potential therapeutic agents for challenging biomedical disorders.
- Preclinical studies and human trials indicate psychedelics may offer novel treatments for addiction, depression, and anxiety.
Purpose of the Study:
- To review current preclinical and clinical findings on psychedelic drugs.
- To explore the pharmacological mechanisms underlying their effects.
- To identify key areas for future research in psychedelic biomedicine.
Main Methods:
- Synthesis of recent preclinical research data.
- Analysis of human neuroimaging studies.
- Review of pilot clinical trial outcomes.
Main Results:
- Psychedelics demonstrate potential therapeutic applications for various intractable disorders.
- Pharmacological mechanisms are being elucidated through combined research approaches.
- Significant questions persist regarding safety, efficacy, and optimal therapeutic use.
Conclusions:
- Psychedelic drugs represent a promising frontier in treating mental health and addiction.
- Continued rigorous investigation is essential to harness their full therapeutic potential.
- Translational research is crucial for advancing psychedelic biomedicine and patient care.
More Related Videos
11:27The Use of Pharmacological-challenge fMRI in Pre-clinical Research: Application to the 5-HT System
Published on: April 25, 2012
16.0K
07:02A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
Published on: February 11, 2019
10.3K
Related Concept Videos
01:22CNS Stimulants: Psychedelic Agents
878
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
878
01:27Hallucinogens and Psychedelics
790
Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
790
01:28An Overview of Psychoactive Drugs
669
Psychoactive drugs impact brain function, influencing perception, mood, consciousness, cognition, and behavior. These substances are grouped based on their effects and the mechanisms by which they act.
Stimulants such as cocaine, amphetamines, and nicotine enhance brain activity, leading to increased alertness, attention, and energy. These drugs typically raise heart rate, blood pressure, and body temperature. While they can induce feelings of euphoria, their misuse can result in severe health...
Stimulants such as cocaine, amphetamines, and nicotine enhance brain activity, leading to increased alertness, attention, and energy. These drugs typically raise heart rate, blood pressure, and body temperature. While they can induce feelings of euphoria, their misuse can result in severe health...
669
01:06Altered States of Awareness
1.2K
Altered states of consciousness represent significant deviations from one's normal mental state. These deviations can range from subtle changes in awareness to profound transformations in perception, thought processes, and sensory experiences. Altered states of consciousness can be triggered by various factors, including drug use, meditation, hypnosis, illness, or even intense fatigue.
The ingestion of substances like stimulants or hallucinogens leads to chemical alterations in the brain...
The ingestion of substances like stimulants or hallucinogens leads to chemical alterations in the brain...
1.2K
01:28Drug Therapy
318
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
318
01:26Psychosis: Goals of Pharmacotherapy
620
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
620